← Back to Clinical Trials
Recruiting NCT07280338

NCT07280338 Emotional Intelligence and Chronic Orofacial Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07280338
Status Recruiting
Phase
Sponsor University Hospital, Brest
Condition Chronic Pain
Study Type OBSERVATIONAL
Enrollment 88 participants
Start Date 2026-02-09
Primary Completion 2027-02-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Questionnaire and Physical Exam

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 88 participants in total. It began in 2026-02-09 with a primary completion date of 2027-02-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic pain, lasting more than three months, is a widespread health issue that negatively impacts daily life, leading to significant emotional distress and functional impairment. Emotional intelligence, defined as the ability to recognize and manage one's own emotions as well as those of others, has been linked to better communication skills and reduced stress, which is a well-known risk factor for chronic pain. Studies have highlighted a correlation between emotional intelligence and certain chronic pain conditions, such as fibromyalgia and migraines. However, no research has yet explored its role in painful temporomandibular disorders (TMD). Given the strong involvement of psychosocial factors in TMD etiology, a better understanding of these elements could improve pain management and pave the way for preventive interventions.

Eligibility Criteria

Inclusion Criteria: For all subjects: Major subject * Non-opposition obtained * For subjects in the TMD group: Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain For subjects in the control group: -No diagnosis of chronic pain Non inclusion Criteria: * Subject not understanding French * Subject under legal protection (guardianship or curatorship) * Refusal to participate

Contact & Investigator

Central Contact

Anais LE FUR-BONNABESSE, Dr

✉ Anais.lefur-bonnabesse@chu-brest.fr

📞 0298223330

Frequently Asked Questions

Who can join the NCT07280338 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07280338 currently recruiting?

Yes, NCT07280338 is actively recruiting participants. Contact the research team at Anais.lefur-bonnabesse@chu-brest.fr for enrollment information.

Where is the NCT07280338 trial being conducted?

This trial is being conducted at Brest, France.

Who is sponsoring the NCT07280338 clinical trial?

NCT07280338 is sponsored by University Hospital, Brest. The trial plans to enroll 88 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology